Aug 5, 2026 · 15 min
Missile shortages collide with Democratic strategy and vaccine politics
Primary Election Results, US Missile Stockpiles Running Low, New Flu Vaccine
The episode connects a consequential Senate primary, wartime weapons constraints, and an FDA decision that could shape the future of mRNA vaccines.
- 1Michigan’s close Democratic Senate primary exposes tensions between progressive outsiders and party establishments before November.
- 2The Iran war has depleted U.S. long-range missiles and Patriot interceptors, raising questions about readiness and support for Ukraine.
- 3Moderna’s mRNA flu vaccine faces an FDA decision amid political opposition to the technology and uncertainty over agency leadership.
Don't miss
Kat Lonsdorf’s report on the Army having used most of its long-range precision missiles makes the war’s hidden resource constraints concrete.
The brief
Tamara Keith examines Michigan’s close Democratic Senate primary between Abdul El-Sayed and Haley Stevens, where outsider-versus-establishment tensions could shape the party’s November strategy.
The race also reflects broader Democratic challenges: bitter primaries, House contests, and pro-Israel outside spending complicate the party’s effort to build a coherent electoral strategy.
Kat Lonsdorf reports that the Army has used most of its long-range precision missiles during the Iran war, while Patriot interceptor shortages raise questions about future conflicts and Ukraine.
The episode then turns to Moderna’s mRNA flu vaccine, whose potential speed and adaptability face political opposition and an uncertain FDA decision under Robert F. Kennedy Jr.
Together, the stories test whether institutions can sustain strategic choices under pressure—from campaign coalitions and weapons stockpiles to vaccine regulation.
Tamara Keith
PRISM
AIPAC
Food and Drug Administration
Robert F. Kennedy Jr.Listen to the full episode and explore every guest, topic, and moment on PodLume.